News

Piramal Pharma Solutions (PPS) announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities. A part…
Read More...

Merck announced its strategic decision to discontinue the development of the investigational combination regimens MK-3682B (grazoprevir/ruzasvir/ uprifosbuvir) and MK-3682C…
Read More...

Amgen and CytomX Therapeutics announced that the companies have entered into a strategic collaboration in immuno-oncology. The companies will co-develop a CytomX Probody™ T-cell…
Read More...

Pfizer unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together is a first-of-its-kind program for patients taking Pfizer Oncology medicines…
Read More...

The U.S. Food and Drug Administration announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to boost the…
Read More...

Kadmon Holdings announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to KD025, the Company’s Rho-associated coiled-coil kinase (ROCK)…
Read More...

Smithers Avanza, a boutique contract research organization (CRO) supporting the pharmaceutical and chemical industries, named Peter Capozziello its new Director, Business Development.…
Read More...

Avara Pharmaceutical Services has signed and closed on an agreement with AstraZeneca to acquire the Reims, France manufacturing and distribution facility. "This key acquisition is…
Read More...

Promethera Biosciences and Shibuya Corporation announced a strategic collaboration to establish a high-throughput, commercial-scale and clinical-grade cell therapy and regenerative…
Read More...

Therapix Biosciences announced that it has entered into an exclusive agreement with Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and…
Read More...

Immatics announced the completion of its Series E financing, raising $58 million. The Series E funding was supported by existing investors including dievini Hopp Biotech holding,…
Read More...

The Alzheimer's Drug Discovery Foundation (ADDF) and Pfizer's Centers for Therapeutic Innovation (CTI) announced they will jointly support a new project that could result in a potential…
Read More...

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for ALUNBRIG® (brigatinib) 180…
Read More...

Lonza announced that it is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire plc. Financial details of the deal were not disclosed. The…
Read More...

Gilead Sciences, Inc. announced a new licensing agreement with the Medicines Patent Pool (MPP), a United Nations-backed public health organization, to expand access to bictegravir (BIC)…
Read More...

Pilgrim Quality Solutions announced the validated release of SmartSolve Out Of Specification (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

GSK announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus…
Read More...

Werum IT Solutions has released a standalone version of its PAS-X KPI software product. PAS-X KPI is the only KPI/OEE tool dedicated solely to the pharmaceutical and…
Read More...

TraceLink announced that Tubilux has selected TraceLink's serialization solutions to help its 30+ European pharmaceutical manufacturing customers comply with the rapidly approaching…
Read More...

NewLink Genetics announced that it has entered into a clinical collaboration agreement with AstraZeneca to evaluate the combination of indoximod, NewLink Genetics’ small molecule IDO…
Read More...